Background Inflammatory responses contribute to tissue damage in COVID-19 and
community-acquired pneumonia (CAP). Although predictive values of different inflammatory …

The objective of the study was to identify distinct patterns in inflammatory immune responses
of COVID-19 patients and to investigate their association with clinical course and outcome …

Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Background COVID-19 is highly contagious, and the crude mortality rate could reach 49% in
critical patients. Inflammation concerns on disease progression. This study analyzed blood …

Objective To explore the clinical value of immune-inflammatory markers to assess the
severity of coronavirus disease 2019 (COVID-19). Methods 127 consecutive hospitalized …

Background The community transmission of coronavirus disease 2019 (Covid-19) was
detected in Baton Rouge, Louisiana, in March 2020. Several previous studies have reported …

Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Background COVID-19 severity has been linked to an increased production of inflammatory
mediators called “cytokine storm”. Available data is mainly restricted to the first international …

Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

Objectives In critically ill patients with COVID-19, distinct hyperinflammatory and
hypoinflammatory phenotypes have been described, with different outcomes and responses …